Patent ID: 8507538
Filing Date: 2013-08-13
Classification: A61P,C07C,C07D,C07F

Abstract:
1. A compound of Formula (I) or a pharmaceutically acceptable salt, ester, prodrug, homolog, tautomer, stereoisomer, or hydrate, or solvate thereof: wherein a dashed line signifies that a single bond or a double bond can be present, provided that there are two double bonds and three single bonds in the ring comprising A A R R wherein a wavy line indicates a point of attachment; X is —NR′R″ or —OR′″; R′ is H, C R″ is H, —SO R′″ is H, C or R′ and R″ taken together with the nitrogen atom to which they are bound form a 4, 5, or 6 membered saturated heterocyclic ring containing 0 or 1 additional heteroatoms where such additional heteroatom is O or N wherein such heterocycle is optionally singly or multiply substituted with substituents independently selected from the group consisting of —OH, oxo, —NH each R each R each R each R each m is independently 0, 1, 2, or 3.